Advanced Biomed (ADVB) Total Current Liabilities (2024 - 2026)

Advanced Biomed has disclosed Total Current Liabilities across 3 years of filings, most recently posting $1.4 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $1.4 million, down 65.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 65.34% YoY), and the FY2025 annual result was $10.1 million, up 269.43% from the prior year.
• Total Current Liabilities came in at $1.4 million for Q1 2026 at Advanced Biomed, up from $1.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $10.1 million in Q2 2025 to a low of $1.3 million in Q4 2025.
• The 3-year median for Total Current Liabilities is $3.0 million (2025), against an average of $3.8 million.
• Peak annual rise in Total Current Liabilities reached 269.43% in 2025, while the deepest fall reached 67.26% in 2025.
• Advanced Biomed's Total Current Liabilities stood at $3.8 million in 2024, then slumped by 67.26% to $1.3 million in 2025, then grew by 13.73% to $1.4 million in 2026.
• The last three Total Current Liabilities figures came in at $1.4 million (Q1 2026), $1.3 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.